Ellen Cahir-McFarland

Company: Annexon Biosciences

Job title: Senior Vice President, Research

Seminars:

Stop the Start: The Effect of Anti-C1q Inhibitors on Neurodegeneration 2:00 pm

C1q tags membranes for elimination via classical complement activation by microglia or macrophages Anti-C1q inhibitors provide synaptic and neuronal protection in multiple mouse models Annexon has developed fit-for-purpose C1q inhibitors for Ophthalmology and Neurodegeneration that have demonstrated proof of biologyRead more

day: Track A - Day 1 PM